Affiliation:
1. Orenburg State Medical University, Orenburg, Russia
Abstract
INTRODUCTION: The development of organ dysfunctions and multiple organ failure (MOF) in patients with severe ischemic stroke (IS) is a factor in aggravating the clinical course and outcome. OBJECTIVE: To study the prognostic aspects of the clinical course and outcomes of severe IS with the development of MOF. MATERIALS AND METHODS: The study included 110 patients with severe IS (National Institutes of Health Stroke Scale ≥ 16 points). To assess the severity of MOF on days 1 and 5 of hospitalization, standard scales SAPS II, SOFA were used. The predictor significance of the indicators was determined by a comparative regression analysis using the least squares method. RESULTS: In patients with a fatal outcome compared to survivors, a higher severity of MOF on the SAPS II was observed both on the first (31 (25; 39) and 24 (21; 29) respectively, p < 0.0001) and fifth days of the disease (40 (33; 49.5) and 29 (25; 35) respectively, p < 0.0001). In the development of severe IS with MOF, an unfavorable outcome is significantly more often observed in the cardioembolic subtype compared to the atherothrombotic subtype of IS (50.75 and 29.85 % respectively, p = 0.0469). The probable mortality according to comparative regression analysis was significantly higher in cardioembolic stroke for patients with MOF severity from 29 to 49 points on the SAPS II (p = 0.0021). CONCLUSIONS: MOF is the most important predictor of death in severe IS. At the same time, the cardioembolic subtype of IS differ by a higher probable mortality in comparison with the atherothrombotic subtype with the MOF severity in the range of 29–49 points according to the SAPS II scale.
Publisher
Practical Medicine Publishing House
Subject
Law,Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine,Emergency Medicine
Reference22 articles.
1. Thomas H., Diamond J., Vieco A., et al. Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control. Glob Heart. 2018; 13(3): 143–63. DOI: 10.1016/j.gheart.2018.09.511
2. Balch M.H.H., Nimjee S.M., Rink C., et al. Beyond the Brain: The Systemic Pathophysiological Response to Acute Ischemic Stroke [published correction appears in J Stroke. 2020; 22(3): 424]. J Stroke. 2020; 22(2): 159–72. DOI: 10.5853/jos.2019.02978
3. Чирков А.Н., Айжанова Л.А., Назаров А.М. и др. Синергетические аспекты математического моделирования нарушений водно-электролитного гомеостаза в острейшем периоде инфаркта мозга. Оренбургский медицинский вестник. 2017; 5(4): 48–55. [Chirkov A.N., Aizhanova L.A., Nazarov A.M., et al. Clinic-prognostic aspects of violations of water-electrolyte homeostasis in the acute period of ischemic stroke. Orenburgskij medicinskij vestnik. 2017; 5(4): 48–55. (In Russ)]
4. Shukla V., Shakya A.K., Perez-Pinzon M.A., Dave K.R. Cerebral ischemic damage in diabetes: an inflammatory perspective. J. Neuroinflammation. 2017; 14: 21. DOI: 10.1186/s12974-016-0774-5
5. Mrozek S., Gobin J., Constantin J.M., et al. Crosstalk between brain, lung and heart in critical care. Anaesth Crit Care Pain Med. 2020; 39(4): 519–30. DOI: 10.1016/j.accpm.2020.06.016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献